Skip to main content

Table 2 Skin conditions after MCM patch treatment during 7 days in DNCB-induced AD mice

From: Effects of mineral complex material treatment on 2,4- dinitrochlorobenzene-induced atopic dermatitis like-skin lesions in mice model

Parameters

Groups

Treatment Days

3

7

1

Barrier Score

NC

80.1 ± 7.3 ***

69.4 ± 6.9 ***

74.6 ± 6.9 ***

DNCB Only

63.7 ± 5.9

55.9 ± 5

53.8 ± 12.2

PC

60.1 ± 4.5

57.3 ± 8.2

57.2 ± 7.8

MCM

65.8 ± 2.3

64.7 ± 4.2 *

63.5 ± 7 *

Barrier Strength

NC

83.8 ± 2.9 ***

76 ± 4.1***

85.8 ± 3.4 ***

DNCB Only

65.1 ± 9.5

53.6 ± 6.7

51.5 ± 22.9

PC

63 ± 5.4

64.5 ± 6.7*

63.2 ± 7.8*

MCM

76.9 ± 4.5 *

75 ± 6.4***

72.8 ± 7.3 ***

Moisture Level

NC

77.1 ± 12.8 ***

61.6 ± 11.4**

59.6 ± 11.6

DNCB Only

54.4 ± 5

50.2 ± 0.4

52.8 ± 5.7

PC

50.2 ± 0.4

54.9 ± 10.3

50.3 ± 0.5

MCM

50.3 ± 0.5

51.3 ± 3.2

55.7 ± 9

Transepidermal Water Loss

NC

7.3 ± 1.6***

10.5 ± 2.07***

6.4 ± 1.9***

DNCB Only

15.9 ± 5.2

22.4 ± 3.3

22.2 ± 11.5

PC

17.2 ± 3.2

19.6 ± 8.3

18.5 ± 3.4

MCM

10.7 ± 2.1

11.1 ± 2.9***

12.8 ± 3.7***

  1. NC Normal control group without any treatment, DNCB only Negative control group treated with DNCB only, PC Positive control group treated with DNCB and tacrolimus ointment, and MCM Experimental group treated with DNCB and MCM patch. Data are expressed as mean ± SD for 8 mice. Significance difference was analyzed with ANOVA and Tukey’s test. *p < 0.05, **p < 0.01, *** p < 0.001 vs. DNCB only group